Regulating Drug Prices while Increasing Innovation.
作者信息
Conti Rena M, Frank Richard G, Gruber Jonathan
机构信息
From the Department of Markets, Public Policy and Law, Questrom School of Business, Boston University, Boston (R.M.C.); the USC-Brookings Schaeffer Initiative on Health Policy, Brookings Institution, Washington, DC (R.G.F.); and the Department of Economics, Massachusetts Institute of Technology, Cambridge (J.G.).
出版信息
N Engl J Med. 2021 Nov 18;385(21):1921-1923. doi: 10.1056/NEJMp2113764. Epub 2021 Nov 13.
PMID:34767322
Abstract
摘要
相似文献
1
Regulating Drug Prices while Increasing Innovation.在促进创新的同时调控药品价格。
N Engl J Med. 2021 Nov 18;385(21):1921-1923. doi: 10.1056/NEJMp2113764. Epub 2021 Nov 13.
2
Drug-Pricing Debate Redux - Should Cost-Effectiveness Analysis Be Used Now to Price Pharmaceuticals?药品定价辩论再探讨——现在是否应该使用成本效益分析来为药品定价？
N Engl J Med. 2021 Nov 18;385(21):1923-1924. doi: 10.1056/NEJMp2113323. Epub 2021 Nov 13.
3
An Incomplete Prescription: President Trump's Plan to Address High Drug Prices.一项不完整的药方：特朗普总统解决高药价问题的计划。
JAMA. 2018 Jun 19;319(23):2373-2374. doi: 10.1001/jama.2018.7424.
4
Accounting for US public funding in drug development: how can we better balance access, affordability, and innovation?解读美国药物研发中的公共资金投入：我们如何能更好地平衡可及性、可负担性与创新？
BMJ. 2020 Oct 8;371:m3841. doi: 10.1136/bmj.m3841.
5
Rebates-The Little-Known Factor Behind Increasing Drug List Prices.回扣——药品目录价格上涨背后鲜为人知的因素。
JAMA. 2020 Mar 3;323(9):812-813. doi: 10.1001/jama.2020.1208.
6
Disclosing Prescription-Drug Prices in Advertisements - Legal and Public Health Issues.在广告中披露处方药价格——法律与公共卫生问题
N Engl J Med. 2018 Dec 13;379(24):2290-2293. doi: 10.1056/NEJMp1814065. Epub 2018 Nov 14.
7
Public research funding and pharmaceutical prices: do Americans pay twice for drugs?公共研究经费与药品价格：美国人是否要为药品支付双倍费用？
F1000Res. 2020 Jul 15;9:707. doi: 10.12688/f1000research.24934.1. eCollection 2020.
8
Revisiting the National Institutes of Health Fair Pricing Condition: Promoting the Affordability of Drugs Developed With Government Support.重新审视美国国立卫生研究院的公平定价条件：促进由政府支持研发的药物的可负担性。
Ann Intern Med. 2020 Mar 3;172(5):348-350. doi: 10.7326/M19-2576. Epub 2020 Jan 28.
9
A New Safe Harbor - Turning Drug Rebates into Discounts in Medicare Part D.一个新的安全港——将药品回扣转化为医疗保险D部分的折扣
N Engl J Med. 2019 May 2;380(18):1688-1690. doi: 10.1056/NEJMp1902692. Epub 2019 Apr 3.
10
Prescription drug prices in the US.美国的处方药价格。
Med Lett Drugs Ther. 2017 May 22;59(1521):81-83.
引用本文的文献
1
Antibody-Drug Conjugates in Solid Tumor Oncology: An Effectiveness Payday with a Targeted Payload.实体瘤肿瘤学中的抗体药物偶联物：靶向有效载荷带来的疗效收获。
Pharmaceutics. 2023 Aug 19;15(8):2160. doi: 10.3390/pharmaceutics15082160.
2
A Proposal to Increase Value and Equity in the Development and Distribution of New Pharmaceuticals.增加新药研发和分配的价值和公平性的提案。
Int J Health Serv. 2022 Jul;52(3):363-371. doi: 10.1177/00207314221100647. Epub 2022 May 12.
Zotero 插件